Cotización Global X Management AUS - ROBO | ADVFN

US Dollar vs MXN

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

Inicio
Invertir
ETFs
Australia
ASX
Global X Management AUS Ltd (ROBO) Cotización

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Último Precio

81.49

Postura de Compra

79.50

Postura de Venta

82.00

Volume Operado de la Acción

3,196

79.51 Rango del Día 81.49

0.00 Rango de 52 semanas 0.00

Capitalización de Mercado [m]

Precio Anterior

79.18

Precio de Apertura

79.60

Hora

Última hora de negociación

Volumen financiero

-

Precio Promedio Ponderado

-

Volumen promedio (3 m)

-

Acciones en circulación

-

Rendimiento del Dividendo

-

Ratio Precio/Utilidad

0.00

Beneficio por acción (BPA)

-

turnover

-12.55M

Beneficio neto

-14.24M

Sector

Real Estate Investment Trust

Industria

Real Estate Investment Trust

Sede

Sydney, New South Wales, Aus

Fundado

-

Global X Management AUS Ltd is listed in the Real Estate Investment Trust sector of the Australian Stock Exchange with ticker ROBO. The last closing price for Global X Management AUS was AUD79.18. Over the last year, Global X Management AUS shares have traded in a share price range of AUD 0.00 to AUD 0.00.

Global X Management AUS currently has 0 shares in issue.

No news to show yet.

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
INTZIntrusion Inc	US$ 2.175 (383.33%)	173.21M
AILEiLearningEngines Inc	US$ 0.6451 (299.44%)	544.72M
HUBCWHub Cyber Security Ltd	US$ 0.036 (260.00%)	2.6M
GTIGraphjet Technology	US$ 0.96887 (186.22%)	389M
LITMSnow Lake Resources Ltd	US$ 1.6895 (91.99%)	117.02M
NEUPNeuphoria Therapeutics Inc	US$ 4.12 (-92.28%)	907.93k
VIRXViracta Therapeutics Inc	US$ 0.1584 (-33.16%)	8.48M
PRFXPainReform Ltd	US$ 3.48 (-28.98%)	887.32k
AIREreAlpha Tech Corporation	US$ 2.658 (-25.75%)	7.86M
ATNF180 Life Sciences Corporation	US$ 2.175 (-23.14%)	503.1k
AILEiLearningEngines Inc	US$ 0.6498 (302.35%)	550.31M
GTIGraphjet Technology	US$ 0.9694 (186.38%)	389.2M
RGTIRigetti Computing Inc	US$ 17.10 (10.75%)	293.2M
XTIAXTI Aerospace Inc	US$ 0.0395 (-1.25%)	247.97M
QSIQuantum Si Inc	US$ 3.6001 (67.45%)	246.15M

ducci1

ducci1 2 minutos hace

WOW There They Go!!

EyeInTheSky

EyeInTheSky 3 minutos hace

"good news" is an understatement.

ducci1

ducci1 3 minutos hace

Wagg 594C .54 ?

koolmc

koolmc 3 minutos hace

sure buddy fyi get your eyes checked

Gooddolphin

Gooddolphin 3 minutos hace

What next NSAV?... As another week goes by.

Huggy Bear

Huggy Bear 3 minutos hace

That is also ... Correct. Unless Foote lied about trying to RS his pet scam again, which given his history of fabrications entirely plausible as well ...

ktcougar

ktcougar 3 minutos hace

It's been a beautiful week! Sold maybe 5% of my Jan. and April calls today. Had to take a little off lol. It's been a December to remember lol!
www.stockscores.com/chart.asp?TickerSymbol=ATOM&TimeRange=30&Interval=120&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=4

gp22

gp22 4 minutos hace

.$SPCB: Israel Security crowd finding..May rip big in AHs. Thats the history of $SPCB

CommodityCoverage

CommodityCoverage 4 minutos hace

Joining Steve Darling from Proactive, First Phosphate's (PHOS.c FRSPF) CEO, John Passalacqua, detailed two major milestones, the first being the signing of two long-term offtake agreements with creditworthy partners marks a pivotal step in securing the future of the company's operations in Saguenay-

MoneyMaker111

MoneyMaker111 4 minutos hace

"FFIE is worth $100/share (January Effect)" -Sources

$FFIE
#FFIE

rbl100

rbl100 4 minutos hace

FDA APPROVES FBIO cancer drug !!!!

FDA approves cosibelimab-ipdl for metastatic or locally advanced cutaneous squamous cell carcinoma

On December 13, 2024, the Food and Drug Administration approved cosibelimab-ipdl (Unloxcyt, Checkpoint Therapeutics, Inc.), a programme

LoveItInBishop

LoveItInBishop 4 minutos hace

Carjockey2

Carjockey2 4 minutos hace

Really chapped arse!!

Imo

$HMB

marcis

marcis 5 minutos hace

The big question is

How much under valued share price does these clingons need to have

Dudes your are dealing with a company of last years rev’s $360!million

Anyone poking to get cheaper is sick IMO

cybldron

cybldron 5 minutos hace

yup keep smoking mr no brain cells left

Mark

Mark 5 minutos hace

$SYRA .44, has a gap on the chart to .80

AugustaFriends

AugustaFriends 5 minutos hace

$WIMI might do next week; what $QSI has done this week run to $4 area -- just a hunch... take it or leave... lots of great plays all over the place.

TenKay

TenKay 5 minutos hace

We still don’t know if FINRA will process one. They didn’t the last time they tried.

ducci1

ducci1 5 minutos hace

Closed 593P .52! Take it! Vix Reverse !!

copytele

copytele 5 minutos hace

ulmadi

ulmadi 5 minutos hace

Absolutely wrong!
The lenders look very closely at what the investment will bring them. And they also look very closely at which products
the company wants to finance with it, what the market is like and how profitable the company can be.
And I see a lot of potential in PHIL.

F14SVF24

F14SVF24 5 minutos hace

Your posts are getting longer and longer. Save your breath. Lies.

Penny Stocks 2.0

Penny Stocks 2.0 6 minutos hace

Not concerned one bit, silver is coming. Strong stock, load up!!

Tiger Money

Tiger Money 6 minutos hace

Also his tweets with saylor from micro were interesting as well. Money is backing kurl for sure as buying has been relentless

Global X Management AUS

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones